Radiofrequency Ablation Study in LatinX Patients

Launched by NORTHWELL HEALTH · Jun 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called radiofrequency ablation (RFA) for LatinX patients who have benign thyroid nodules that are causing discomfort, cosmetic issues, or hormonal problems. Unlike traditional surgery, which involves removing part or all of the thyroid gland, RFA is a less invasive procedure that can be performed outside of an operating room. The researchers want to find out if RFA is a safe and effective option for these patients who prefer to avoid surgery.

To be eligible for this study, participants must be over 18 years old, self-identify as LatinX, and have a benign thyroid nodule that meets certain criteria. This means the nodule should have clear edges on an ultrasound and be surrounded by healthy thyroid tissue. Participants can expect to follow specific study procedures and be monitored throughout the trial. It's important to know that certain individuals, such as pregnant women or those with specific medical devices, will not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject capable of giving informed consent
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Subjects over 18 years of age
• • Subject who self-identifies as LatinX
• • Subjects who have a benign, symptomatic thyroid nodule
• • Subjects whose nodule has well-defined margin on ultrasound and is surrounded by at least 2mm of normal thyroid parenchyma in all directions
• Exclusion Criteria:
• • Patients who are pregnant, trying to become pregnant, or breastfeeding
• • Patient who have a cardiac pacemaker,defibrillator , or other electromedical equipment
• • Patients who have a nodule that is malignant or not predominantly solid (must be \>50% solid by ultrasound)
• • Patients who cannot give consent
• • Patients on anticoagulation or dual antiplatelet therapy
• • Patients with acute illness
• • People with BP \> 140/90 prior to the scheduled procedure